| answer text |
<p>Since 2014, community pharmacy contractors have been required to conduct 70% of
the Medicines Use Reviews (MURs) that they undertake on the following target groups
and data is collected accordingly:</p><p>- Patients taking high-risk medicines (Non-steroidal
anti-inflammatory drugs, anticoagulants, antiplatelets and diuretics);</p><p>- Patients
recently discharged from hospital;</p><p>- Patients prescribed a respiratory drug,
as specified; and</p><p>- Patients regularly prescribed four or more medicines, at
least one of which is for a risk of cardiovascular disease, as specified.</p><p>Specific
data is not collected on the remaining 30% and so it is not possible to say how many
people taking medicines for Parkinson’s disease have received an MUR.</p>
|
 |
